Skip to content

← All news

Earnings

Vivos Therapeutics reports 35% revenue increase in Q2 2026

2 sources ·2 articles ·Aug 14, 22:27 UTC Vivos Therapeutics Vivos

2 outlets - including Seekingalpha and Investing - are covering this story.

Covered by 2 outlets

Seekingalpha 1 Investing 1

All coverage · 2 articles

Seeking Alpha ·Aug 14, 22:27 UTC

Vivos Therapeutics, Inc. (VVOS) Q2 2026 Earnings Call Transcript

Investing.com UK ·Aug 14, 20:34 UTC

Vivos Therapeutics reports 35% revenue increase in Q2 2026